Dr. Bhimraj is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6560 Fannin St
Ste 1540
Houston, TX 77030Phone+1 713-799-9997Fax+1 713-799-2511
Education & Training
- UPMC Medical EducationFellowship, Infectious Disease, 2006 - 2008
- Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 2003 - 2006
- Gandhi Medical CollegeClass of 1999
Certifications & Licensure
- TX State Medical License 2022 - 2025
- OH State Medical License 2009 - 2023
- PA State Medical License 2003 - 2009
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Retrospective Analysis of Clinical Features in Ventriculoperitoneal Shunt Infectionsin Adults Start of enrollment: 2007 Aug 01
Publications & Presentations
PubMed
- 405 citationsInfectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022).Adarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, Lindsey R Baden, Vincent Chi-Chung Cheng
Clinical Infectious Diseases. 2024-06-27 - 219 citationsSevere covid-19 pneumonia: pathogenesis and clinical management.Amy Attaway, Rachel G. Scheraga, Adarsh Bhimraj, Michelle Biehl
BMJ. 2021-03-10 - 438 citationsInfectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker, Valery Lavergne, Lindsey R. Baden
Clinical Infectious Diseases. 2020-04-27
Press Mentions
- A Crucial Group of Covid Drugs Has Stopped WorkingFebruary 8th, 2023
- Anti-Inflammatory Agents May Have Role in COVID-19 PneumoniaOctober 25th, 2022
- Ivermectin: Still on a Losing Streak as COVID-19 TreatmentOctober 22nd, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: